Crea Creatinine assay Kit (Enzymatic method)
In vitro test for the quantitative determination of creatinine (Crea) concentration in serum, plasma and urine on photometric systems. Creatinine measurements are used in the diagnosis and treatment of renal diseases, in monitoring renal dialysis, and as a calculation basis for measuring other urine analytes.
Storage and stability
Up to expiration date indicated on the label, when stored unopened at 2-8 ℃ and protected from light.
Once opened, the reagents are stable for 28 days when refrigerated on the analyzer or refrigerator. Contamination of the reagents must be avoided.
Do not freeze the reagents.
Principle
It involves 2 steps
Reagents preparation
Component |
Concentrations |
Reagents 1(R1) |
|
Tris Buffer |
100 mmol |
Sarcosine Oxidase |
6 KU/L |
Ascorbic acid oxidase |
2 KU/L |
TOOS |
0.5 mmol/L |
Surfactant |
Moderate |
Reagents 2(R2) |
|
Tris Buffer |
100 mmol |
Creatininase |
40 KU/L |
Peroxidase |
1.6 KU/L |
4-aminoantipyrine |
0.13 mmol/L |
Sample requirements
Serum, plasma and urine are suitable for samples. Whole blood and hemolysis are not recommended for use as a sample. Freshly drawn serum is preferred specimen.
Method
1. Reagent preparation :Liquid reagent can be used when opened
2. Measurement
Main wavelength |
546 nm |
Sub wavelength |
700nm |
Temperature |
37℃ |
Type |
2-Endpoint |
Sample (calibrator) |
4μL |
||
R1 |
180μL |
||
Mix and keep at 37℃, 5 min, determination of absorbance A1. |
|||
R2 |
60 μL |
||
Mix and keep at 37℃, 5 min, determination of absorbance A2. |
△A=[(A2-A1)sample / calibrator]-[(A2-A1) blank]
Calibration
Two-point calibration with purified water and CREA calibrator. Calibrators are sold separately, RANDOX or other traceable calibrators are recommended.
Quality control
At least two levels of control material should be analyzed with each batch of samples.Each laboratory should establish its own internal quality control scheme and procedures for corrective action if controls do not recover within the acceptable tolerances.
Reference intervals [1,2]
Each laboratory should establish its own reference intervals based upon its patient population. The reference intervals measured at 37℃ listed below were taken from literature:
Serum/Plasma:
Male 0.8-1.3 mg/dL; 70-115 μ mol/L
Female 0.5-0.9 mg/dL; 44-88μmol/L
Urine/First :
Male 40-278mg/dL; 3540~24600mmol
Morning urine Female 29-226mg/dL; 2550~20000mmol
Urine/24H:
Male 980-2200mg/24h;8600-19400μmol/24h
Female 720-1510mg/24h;6300-13400μmol/24h
Interferences/specificity
The following substances were tested for interference with this methodology. Criterion: Recovery within ±10 % of initial value.
Substance |
Level Tested |
Observed Effect |
Ascorbic acid |
1704μmol/L |
NSI* |
Bilirubin |
425μmol/L |
NSI |
Lipemia |
1000 mg/dL |
NSI |
Hemoglobin |
200 mg/dL |
NSI |
* NSI: No Significant Interference (within ± 10 %) |
Reagent blank absorbance
The absorbance of reagent blank at 546 nm should be <0.3.
Sensitivity
When testing 100 μ mol/L creatinine, the absolute value of the absorbance difference should not be less than 0.01.
Precision
Within-run : CV≤4%
Between-run: CV≤6%
Linearity range
1) In the range of 20-2000μmol/L, the correlation coefficient r should not be less than 0.990;
2) In the range of [20-70] μmol/L, the absolute deviation between the measured concentration and the estimated value should be within the range of ±7 μmol/L; (in the range of 70-2000] μmol/L, the relative deviation between the measured concentration and the estimated value should be not more than ±10%.
Warnings and precautions
1. For in vitro diagnostic use.
2. Take the necessary precautions for the use of laboratory reagents.
3. Preservative contained. Do not swallow. Avoid contact with skin and mucous membranes.
4. Disposal of all waste material should be in accordance with local guidelines.
5. Material safety data sheet is available on request for professional users.
References
[1] Tietz Textbook of Clinical Chemistry, 3rd edition. Burtis CA, Ashwood ER. WB Saunders Co., 1999.
[2] Heinegard, D., Tiderstrom, G., Clin. Chem. Acta, 43:305 310 (1973).
[3] National Committee for Clinical Laboratory Standards, How to Define,Determine, and
Utilize Reference Intervals in the Clinical Laboratory, Approved Guideline, CLSI publication C28-A, Villanova, PA(1995).